Juergen Wastl
A Molecular Biologist & Biochemist by training, I slowly grew into project management and strategy in Industry and Higher Education. As leader of the Digital Science Consultancy team, I will expand the range of activities with which the Consultancy team engages. Our team of data scientists, developers and subject matter experts numbers over 80 across the Digital Science portfolio and already supports research institutions, funders, governments and other institutions aligned to research to make more and better use of data to inform their strategies and decisions.
Previously I headed the Research Information team at the University of Cambridge with responsibilities for managing and implementing software tools for Academics and Administrators (Symplectic, Altmetric, Dimensions, Research Professional, ORCID and VIVO), provision of analysis (including network and collaboration analysis) for Collegiate Cambridge and acted as Deputy REF Manager.
Articles by Juergen Wastl
Fragmentation: The Divided Research World – Part Two, Siloed Knowledge
January 2024 marks the start of the second phase of our ‘Fragmentation of Research’ Campaign with a focus on the sub-theme, ‘siloed knowledge’. We will explore the fragmentation of research from the viewpoint of those areas of research where a lack of integration reveals instances where research findings remain isolated, limiting their broader applicability across the research ecosystem.
A tale of two pharmas – Global North and Global South
In this blog we present findings from a bibliometric evaluation of scientific publications that include a contribution from the top ten pharmaceutical companies in the Global North and Global South, which have been indexed in Digital Science’s Dimensions database in the past five years (2018 to 2022). The study maps aspects of the landscape in this area exploring differences in pharmaceutical research practices from different perspectives including funding and collaboration, pharmaceutical research and its association with the SDGs, the impact of the cost of medicines developed by pharma and their accessibility in distinct geographic regions. The results show significant gaps between the two global areas, but also some ways where these gaps are now closing.
Fragmentation: a divided research world?
Research has the power to change lives, break down barriers and create unity & equity. When the research community solves problems together extraordinary breakthroughs can happen.
But post-pandemic, fragmentation in the research ecosystem remains one of the biggest challenges to the ability of researchers to make a real-world difference. We want to challenge the status quo, highlight the issues, and share positive ways to create better synergy and collaboration, helping to unite a divided research world.
A multi-dimensional approach to assessing the impact of the UN’s Sustainable Development Goals (SDGs)
In this short, informal interview, Dr Briony Fane and Dr Juergen Wastl explain some of the methods behind their work on assessing how global research ties into the UN's Sustainable Development Goals. If you're new to SDGs and want to get a quick idea of how to look at them through a number of different lenses, this is the introduction for you.
